Hot Flashes

Daniel S. Childs; Arjun Gupta; Cindy S. Tofthagen; Charles L. Loprinzi

doi:10.1007/978-3-030-75377-1_3

Hot Flashes

Daniel S. Childs, Arjun Gupta, Cindy S. Tofthagen, Charles L. Loprinzi

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Hot flashes are common in breast cancer survivors because they can occur as a result of natural aging, surgery, or medications used in the treatment of cancer. Unfortunately, some survivors will have to cope with bothersome hot flashes for years even after completing cancer-directed therapies, and these symptoms can detrimentally impact life quality in multiple domains. Many drug and non-drug interventions have been studied in recent decades, and some are quite effective at reducing the frequency and severity of hot flashes. This chapter provides a succinct overview of supportive care strategies for dealing with hot flashes, the data behind each approach, and important information about toxicities that may occur as a result of therapies.

Original language	English (US)
Title of host publication	Common Issues in Breast Cancer Survivors
Subtitle of host publication	A Practical Guide to Evaluation and Management
Publisher	Springer International Publishing
Pages	25-38
Number of pages	14
ISBN (Electronic)	9783030753771
ISBN (Print)	9783030753764
DOIs	https://doi.org/10.1007/978-3-030-75377-1_3
State	Published - Jan 1 2021

Keywords

Antidepressants
Gabapentinoids
Hot flashes
Non-estrogenic therapies
Oxybutynin
Vasomotor symptoms

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-3-030-75377-1_3

Cite this

@inbook{e26c83aba1ca4c2c96b6fef6119eb9d0,

title = "Hot Flashes",

abstract = "Hot flashes are common in breast cancer survivors because they can occur as a result of natural aging, surgery, or medications used in the treatment of cancer. Unfortunately, some survivors will have to cope with bothersome hot flashes for years even after completing cancer-directed therapies, and these symptoms can detrimentally impact life quality in multiple domains. Many drug and non-drug interventions have been studied in recent decades, and some are quite effective at reducing the frequency and severity of hot flashes. This chapter provides a succinct overview of supportive care strategies for dealing with hot flashes, the data behind each approach, and important information about toxicities that may occur as a result of therapies.",

keywords = "Antidepressants, Gabapentinoids, Hot flashes, Non-estrogenic therapies, Oxybutynin, Vasomotor symptoms",

author = "Childs, {Daniel S.} and Arjun Gupta and Tofthagen, {Cindy S.} and Loprinzi, {Charles L.}",

note = "Publisher Copyright: {\textcopyright} Springer Nature Switzerland AG 2021.",

year = "2021",

month = jan,

day = "1",

doi = "10.1007/978-3-030-75377-1_3",

language = "English (US)",

isbn = "9783030753764",

pages = "25--38",

booktitle = "Common Issues in Breast Cancer Survivors",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Hot Flashes

AU - Childs, Daniel S.

AU - Gupta, Arjun

AU - Tofthagen, Cindy S.

AU - Loprinzi, Charles L.

N1 - Publisher Copyright: © Springer Nature Switzerland AG 2021.

PY - 2021/1/1

Y1 - 2021/1/1

N2 - Hot flashes are common in breast cancer survivors because they can occur as a result of natural aging, surgery, or medications used in the treatment of cancer. Unfortunately, some survivors will have to cope with bothersome hot flashes for years even after completing cancer-directed therapies, and these symptoms can detrimentally impact life quality in multiple domains. Many drug and non-drug interventions have been studied in recent decades, and some are quite effective at reducing the frequency and severity of hot flashes. This chapter provides a succinct overview of supportive care strategies for dealing with hot flashes, the data behind each approach, and important information about toxicities that may occur as a result of therapies.

AB - Hot flashes are common in breast cancer survivors because they can occur as a result of natural aging, surgery, or medications used in the treatment of cancer. Unfortunately, some survivors will have to cope with bothersome hot flashes for years even after completing cancer-directed therapies, and these symptoms can detrimentally impact life quality in multiple domains. Many drug and non-drug interventions have been studied in recent decades, and some are quite effective at reducing the frequency and severity of hot flashes. This chapter provides a succinct overview of supportive care strategies for dealing with hot flashes, the data behind each approach, and important information about toxicities that may occur as a result of therapies.

KW - Antidepressants

KW - Gabapentinoids

KW - Hot flashes

KW - Non-estrogenic therapies

KW - Oxybutynin

KW - Vasomotor symptoms

UR - http://www.scopus.com/inward/record.url?scp=85169373618&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85169373618&partnerID=8YFLogxK

U2 - 10.1007/978-3-030-75377-1_3

DO - 10.1007/978-3-030-75377-1_3

M3 - Chapter

AN - SCOPUS:85169373618

SN - 9783030753764

SP - 25

EP - 38

BT - Common Issues in Breast Cancer Survivors

PB - Springer International Publishing

ER -

Hot Flashes

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this